Loïc Le Ribault

Loïc le Ribault (1947-2007) studied silica in all its scientific aspects for more than 30 years. In two articles published in 1972 by the Academy of Sciences, Le Ribault demonstrates that certain quartz crystals contain on their surface an amorphous layer of silica, which is soluble in water. After studying thousands of samples, he establishes the frequent presence of microorganisms, as bacteria and diatoms, on the surface of certain grains of sand [I].

Later he demonstrates that the superficial amorphization of dendritic quartz is caused by the combined action of these microorganisms, by means of organic acid which they secrete and mechanical and/or chemical actions characteristic for the sedimentary environment were they evolve [II].

In order to study more deeply the role of the microorganisms in the biologic silica cycle, Le Ribault creates, in1975, a procedure that allows collecting silica deposits produced by the action of the microorganisms. Afterward, it will be demonstrated that these obtained solutions contain a significant percentage of silica in organic form. During these experiments was successfully discovered the therapeutic efficiency of organic silica.

At that time, Le Ribault was suffering from psoriasis, that was considered incurable and was affecting his both hands and his nails. After removing with his hand's grains of sand rich in organic silica, in order to study them with an electronic microscope, he was surprised to notice that, after few days, psoriasis disappeared from his right hand. Intrigued, he began searching for a cause-effect relation, realizing the same operation with his left hand in the same silica solution and obtaining the same result. As a consequence of this, Le Ribault begins to analyze the role of organic silica in treating skin conditions, creating, in collaboration with other doctors, hundreds of tests till 1982 with very positive results.

During this period of time, he perfections the method of natural extraction of organic silica, from certain types of dendritic silica sand providing to other professionals solutions of therapeutic use that, historically, can be qualified as G3 (third generation).

Surprised, the doctors determine rapidly that the treated patients affirm to be relieved from the joint pain, feeling much better. By means of blood analysis it was also demonstrated that in case of those affected by viral disorders, the improvement is rapid. In other words, the organic silica seems to act positively in a multitude of diseases.


In 1982, the chemic Duffaut and the doctor Le Ribault have met during a scientific event in Bordeaux. Duffaut was for several years analysing a synthetic molecule of organic silica. Le Ribault was heading a very sophisticated microanalysis material, as he created the famous microanalysis laboratory CARME. Immediately the both scientists initiated their collaboration on the therapeutic application of organic silica.


The next year, the collaboration of the scientists led to the synthesis of a very efficient molecule in the treatment of viral diseases: the G4 called DNV, obtained by adding sodium hyposulphite. During almost a decade, Duffaut and Le Ribault accumulate evidence of the high-efficiency of the organic components in treating a high number of diseases. They were treating costless hundreds of patients trying, year after year, to improve the organic silica solutions. 


After the death of Duffaut, Le Ribault continues the work alone. Till then, the organic silica solutions were exclusively for external topic use, and in order to activate them, it was necessary to add small quantities of products used in allopathy and homeopathy, which were selected in a special way according to every disease. They were presenting many problems as a short lifetime, because over time they were precipitating and polymerizing, becoming unstable.

In 1994 Le Ribault creates a new molecule, tested for 3 years, which had an advantage: the lack of need to add more drugs in order to reinforce its effect. The molecule was more effective than the precedent ones and also was totally stable. Over time it will be demonstrated that the molecule maintains its stability during years and can also be used orally during lots of time. Its toxicity, a big problem for the precedent types of silica is equivalent to the toxicity of the water. According to Le Ribault, the monomethylsilanetriol molecule of organic silica is atomically unstable, because of its constant reorganization and it also presents a high vibration force. The fact that such a labile molecule can be stabilized was a great success for this formula. The other improvement which is also a reason of its efficiency is its pureness. Le Ribault obtained a totally organic molecule, a purified one, without any contamination of silandiols or other components which were inevitably founded in the precedent silica solutions. This product was called organic silica of the fifth generation (G5) because of the work which culminated 4 precedent levels trying to stabilize organic molecules of silica.


The monomethylsilanetriol stabilized due to the method of Loïc Le Ribault, demonstrated its therapeutic efficiency. On the other hand, silicic acid is a molecule that is assimilable but, in practice, it tends to polymerize easily becoming inactive or even harmful to the body. However, Dr. Le Ribault, a pioneer in the use of the scanning electron microscope, and also in the study of silica forms in geology, discovered a method of silicic acid stabilization through a chemical component. This is the origin of the so-called G5 Siliplant product, formula created in 2006. 



Silicic acid stabilized through a chemical component

The career of Doctor Le Ribault:

 1970-1973: Investigator at the Laboratory of Oceanography at the Orsay University.

 1973-1981: Head of Department of Electronic Microscopy at the official headquarter of the Central Laboratory TOTAL.

 1981-1990: Founder and General Director of CARME Laboratory (Centre d’Applications et de Recherches en Microscopie Electronique)

 1990-1993: International expert in criminalistics, founder of the LE RIBAULT EXPERTISES society.

1993-2004: Independent investigator in different fields and projects with molecules of therapeutic interest. The launching of the G5. The foundation of the company in Ireland.

2004-2007: In Spain is established the definitive quarter that will serve as a base for the future international retail of G5. With the funding of the Spanish company Silicium, it is initiated a successful collaboration that put into practice several projects that were not finished. The most notorious project is the stabilization of the silicic acid through an organic complex called Siliplant.

 06/06/2007: The death of Dr. Loïc Le Ribault.